CHYM CHYM
Company Profile ↓Company Overview
CHYM (CHYM) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 30.8% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.09.
Recent Developments
- Dec 2025 Revenue of $2.19B (+30.7% YoY); net profit $-1.01B.
- Trailing 12 Months Year-on-year growth — revenue +30.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 30.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 30.79% |
| 1 Year: | 30.69% |
Stock Price Performance
| 1 Year: | -23.51% |
| 6 Months: | +18.57% |
| 3 Months: | +24.68% |
| 1 Month: | +22.73% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)76.64 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 30.8% over 5 years.
CONS
- In a downtrend (50-DMA below 200-DMA).
- RSI at 77 suggests overbought conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | 384.21M | 421.87M | 518.74M | 528.15M | 543.52M | 596.36M | 647.39M |
| Cost of Revenue | - | - | - | 60.42M | 67.12M | 69.40M | 66.11M | 67.07M |
| Gross Profit | - | 333.71M | 368.36M | 458.33M | 461.03M | 474.12M | 530.25M | 580.31M |
| Operating Expenses | - | - | - | 449.19M | 1.39B | 538.83M | 584.02M | 534.15M |
| Operating Income | - | -9.44M | -30.64M | 9.14M | -930.64M | -64.71M | -53.77M | 46.16M |
| EBITDA | - | - | - | 16.39M | -923.23M | -57.20M | -45.95M | 53.83M |
| Interest Expense | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | 14.49M | -924.42M | -54.44M | -44.73M | 53.91M |
| Tax Provision | - | - | - | 1.55M | -1.05M | 280.00K | 46.00K | 455.00K |
| Net Income | 15.90M | 385.00K | -22.03M | 12.94M | -923.38M | -54.72M | -44.78M | 53.46M |
| Diluted EPS | - | 0.00 | -0.34 | 0.00 | -7.29 | -0.15 | -0.12 | 0.13 |
| R&D Expense | - | 75.37M | 80.40M | 77.88M | 621.75M | 123.94M | - | 109.78M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 1.28B | 1.67B | 2.19B |
| Gross Profit | 1.06B | 1.47B | 1.92B |
| Operating Income | -235.78M | -62.20M | -1.04B |
| Net Income | -203.20M | -25.34M | -1.01B |
| Diluted EPS | -3.22 | -0.39 | -4.27 |
| R&D Expense | 259.00M | 309.57M | 934.92M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | - | - | 1.46B | 1.96B |
| Total Equity | -1.79B | -1.95B | -1.93B | 1.40B |
| Cash & Equivalents | - | 239.75M | 337.70M | 466.25M |
| Total Liabilities | - | - | 501.52M | 562.90M |
| Current Liabilities | - | - | 374.82M | 387.92M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | -156.59M | 64.14M | 52.78M |
| Investing Cash Flow | 167.01M | 45.66M | -289.69M |
| Financing Cash Flow | 842.00K | 456.00K | 367.67M |
| Share Buybacks | 61.00K | 950.00K | 77.54M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | 82.8% | 87.6% | 88.0% |
| Operating Margin % | -18.4% | -3.7% | -47.6% |
| Net Margin % | -15.9% | -1.5% | -46.2% |
| ROE % | 10.4% | 1.3% | -72.1% |
| ROCE % | - | -5.7% | -66.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CHYM
Chime Financial Stock Climbs 21% On A 7-Day Winning Streak - Trefis
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOZE1DUktLSFBwbDhHa01EVHNpRmV3OG9oTU5oWXlLX3U4aUlnZ2VLbnlCU0IxY0Y4YkRsZTZuT3FzNGx0SUpvTW45eFBzQ0dmTUpHbnBUdEYyMHNzMTQyMzVIRUh5ckZrLV9sV2JuRUVvRFB3bDM0d2hrdXREY1VXS0FfYmJrb3BtY21UVV…
Chime Financial Stock Surges 21%, With A 7-Day Winning Spree - Trefis
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxQWm9ya1BGdmY5eE5NM1VNZkhUeW1ESzQ2bmU3SDAtM3gtTGZKTjdZcTFOVnV0ZjEwbHM4LThZbXFqTmhJd0x0SVc3Yjh4cUVRRWhKRmdqMWw1XzJEUFlCZHY5UHI2VTlDWjJocWJabnlxLWY5bzlFZ21kdzFwTndYdUpEWHJoZ3BYakxncH…
Allied Universal Will Offer Chime Workplace at No Cost to About 320K - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxOQ3hTeDJDY2hZMDJadHlmNlNzZVN2ZXg5MjE4ZmhmY2kwT1R1NjBzRXUtMEZxTVBjcXY5X1dhTTdLSjM2UTRPMG5sWGNGb0s1NFY1bVRCek0tcnVCUFdxOU1adjFRclFWbndDQm51Y3lrbVdtRVNrQjZQT2ZQRXR1TXY3cWZtUWVJdWJlT2…
(CHYM) Chime Now Expects 2026 Revenue Range $2.725B-$2.745B, vs. FactSet Est of $2.68B - marketscreener.com
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxPeGgtb3RuSjVfVkVFeGZCWmNNVDJoWi0zM1FBMDNXSTNGTzl3SDBiN2NvR3g3ck1WMk42S2xvVDd4cnNOQ2Nhd1pmanZxZ2RqMXh3WExWR3pzaTFPYWYyNl85ODhSVjhBR1BMV2M4aUI4TVFjWVdSa2dKX1g4NGpmeXRKQUtWNTBLa0ZzTH…
Chime (CHYM) Stock Looks Reasonable With Shares Below Fair Value - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxOSHdUTHdWellUWVRldlRCeEhraEZabGVnQ0JJN1J4N3F0VWNEcXpCaEVjRDJJeHN4czZhWGV2bk9xU0ZxR3g1dnhBMGc5ZDRrQlFyVW5rejltdmFZREsyMjdKa2hKQVBBd2ZNYkJNQWVEZThzbFM4LWFCQzRXR0k4VUZwWkRzTlBiZ0hnOU…
AMS Capital Ltda Takes Position in Chime Financial, Inc. $CHYM - MarketBeat
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQd2VtYm1Hb2VJMjVIY3hLeFRSSFNINndzOUkzMUgzUzB2QlA1ZGxFRU9Ram1OeF9vcjJWeUxXMW5pdmVjeEVDQjZKZUdaOGNqZ3M0blFfeU8yX3otaGNfTjZnM2V4TkV5VHlQOW9kRU1SbFBqOXJ4M2xKcHZSTGdDUUYxZlBTek85TGZZNT…
CHYM — Frequently Asked Questions
What is the current share price of CHYM?
As of 2026-08-05 17:25 PDT, CHYM trades at $25.92 on NASDAQ/NYSE. Its 52-week range is $16.44 to $33.88.
What is the P/E ratio of CHYM?
CHYM trades at a trailing price-to-earnings (P/E) ratio of -6.07.
What is the return on equity (ROE) of CHYM?
CHYM has a return on equity (ROE) of -72.05%. Its return on capital employed (ROCE) is -65.96%.
Is CHYM a good stock to buy?
This page provides a data-driven analysis of CHYM, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.